Skip to content

Clinical trials

Phase 2 Glioblastoma trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 2 Country / region: Australia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20131
20152
20172
20182
20192
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Active, not recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
AbbVie1
Apollomics Inc.1
Children's Oncology Group1
Eli Lilly and Company1
Ludwig Institute for Cancer Research1
Merck Sharp & Dohme LLC1
Nationwide Children's Hospital1
Northern Sydney and Central Coast Area Health Service1
PharmAbcine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma13
Astrocytoma4
Brain Neoplasms4
Glioma4
Diffuse Intrinsic Pontine Glioma2
Oligodendroglioma2
Pancreatic Neoplasms2
Stomach Neoplasms2
Biliary Tract Neoplasms1
Colonic Neoplasms1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.